Patent application number | Description | Published |
20080205327 | Methods, Apparatuses, and Computer Program Products for Providing Dynamic Assignment of Slot Cycle Index for Network Nodes - An apparatus for providing dynamic assignment of slot cycle index includes a processing element. The processing element may be configured to send a registration message to a server for registering a network node to a service associated with the server, to receive a response to the registration message from the server in which the response identifies slot cycle index information, and to apply a slot cycle value at the network node based on stored information defining the slot cycle value corresponding to the identified slot cycle index information. | 08-28-2008 |
20080209522 | Method, Apparatus, and Computer Program Product for Authenticating Subscriber Communications at a Network Server - An apparatus for authenticating subscriber communications at a network server includes a determining element and an identification element in communication with the determining element. The determining element may be configured to receive an incoming message. The identification extractor may be configured to extract a device identifier and an address identifier from the incoming message. The determining element may be further configured to determine whether the device identifier and the address identifier of the incoming message match both a registered device identifier and a registered address identifier associated with the registered device identifier, respectively. | 08-28-2008 |
20080225831 | Methods, Apparatuses, and Computer Program Products for Processing Session Related Protocol Signaling Measures - An apparatus for processing session related protocol signaling messages includes a simplification element. The simplification element may be configured to receive a message associated with a session related protocol, to determine whether the message is a per call based message and, in response to a determination that the message is the per call based message, to interpret the per call based message without the removed per session based information. The per call based message is free of per session based information that has been removed. | 09-18-2008 |
20080233944 | Method, Apparatus, Computer Program Product and System for Providing Dynamic Assignment of Session Capabilities - An apparatus for providing dynamic assignment of session capabilities such as buddy list capabilities includes a processing element. The processing element may be configured to receive a message associated with a communication session with a network node, acquire service plan based capabilities associated with the network node, receive device based capabilities associated with the network node, and determine session based capabilities associated with the service based on the device based capabilities and the service plan based capabilities on a per subscriber basis. | 09-25-2008 |
20080256244 | Method, Apparatus, Computer Program Product and Network Node for Providing Remote Client Deactivation - An apparatus for providing remote client deactivation includes a processing element. The processing element may be configured to receive a message associated with a service related to a communication session with a client, determine whether the client is associated with an indication to deactivate the client and communicate a signaling message to deactivate the client in response to a determination that the client is associated with the indication to deactivate the client. | 10-16-2008 |
20080270542 | Method, Apparatus, and Computer Program Product for Reducing Session Related Message Size - An apparatus for reducing session related message size includes a processing element. The processing element may be configured to determine a domain-wide unique identifier and generate a message including a first field for identifying a message sequence associated with the message and a second field including a tag. The second field including the tag may be associated with an identifier of a source or recipient of the message. At least one of the first and second fields may be without data. The processing element may be further configured to include, in the message, a third field comprising at least the domain-wide unique identifier. The third field may be associated with data otherwise intended for the first and second fields. | 10-30-2008 |
20080285451 | Method, Apparatus, and Computer Program Product for System Selection During Service Acquisition - An apparatus for system selection includes a processing element. The processing element may be configured to commence a search for a network service system, determine whether a real-time application is active, and select a network service system in response to a determination that the real-time application is active according to a preference order that is different than an order of preference for network service systems for use if the real-time application is not active. | 11-20-2008 |
20120165061 | METHOD, APPARATUS, COMPUTER PROGRAM PRODUCT AND SYSTEM FOR PROVIDING DYNAMIC ASSIGNMENT OF SESSION CAPABILITIES - An apparatus for providing dynamic assignment of session capabilities such as buddy list capabilities includes a processing element. The processing element may be configured to receive a message associated with a communication session with a network node, acquire service plan based capabilities associated with the network node, receive device based capabilities associated with the network node, and determine session based capabilities associated with the service based on the device based capabilities and the service plan based capabilities on a per subscriber basis. | 06-28-2012 |
20120207157 | METHOD, APPARATUS, AND COMPUTER PROGRAM PRODUCT FOR REDUCING SESSION SETUP LATENCY - An apparatus for reducing session setup latency includes a processing element. The processing element is configured to determine a status with respect to a response message made in response to an invite message associated with a communication session, determine a status with respect to media packets being communicated between nodes of a network, make a determination with respect to an acknowledgment message based at least in part on the status determination with respect to the response message and the status determination with respect to media packets, and control setup of a communication session based on the determination with respect to the acknowledgement message. | 08-16-2012 |
20140181225 | METHOD, APPARATUS, AND COMPUTER PROGRAM PRODUCT FOR REDUCING SESSION RELATED MESSAGE SIZE - An apparatus for reducing session related message size includes a processing element. The processing element may be configured to determine a domain-wide unique identifier and generate a message including a first field for identifying a message sequence associated with the message and a second field including a tag. The second field including the tag may be associated with an identifier of a source or recipient of the message. At least one of the first and second fields may be without data. The processing element may be further configured to include, in the message, a third field comprising at least the domain-wide unique identifier. The third field may be associated with data otherwise intended for the first and second fields. | 06-26-2014 |
Patent application number | Description | Published |
20090129723 | PROGRAMMABLE OPTICAL ARRAY - An apparatus having a topology that allows building complicated optical programmable arrays useful for manipulating the phase and/or amplitude of an optical signal. Sophisticated filtering and other optical signal processing functionality can be programmed into the array after a chip containing the array has been fabricated. This programming capability is analogous to that of electronic field programmable gate arrays (FPGA's). Apparatus described herein will provide a powerful tool for processing optical signals or very broadband electrical signals. | 05-21-2009 |
20090154940 | BALANCED OPTICAL SIGNAL PROCESSOR - An apparatus and method for reducing electrical signal intermodulation by processing a balanced electrical signal in the optical domain in a manner adapted to reduce noise and second order intermodulation, and converting the processed optical signal back to an electrical domain signal with either a single or balanced (differential) outputs. | 06-18-2009 |
20090214223 | CMOS-COMPATIBLE TUNABLE MICROWAVE PHOTONIC BAND-STOP FILTER - According to one embodiment, a microwave photonic band-stop (MPBS) filter uses an electrical input signal to drive an optical Mach-Zehnder modulator. A modulated optical carrier produced by the modulator is applied to an optical filter having at least two tunable spectral attenuation bands that are located substantially symmetrically on either side of the carrier frequency. The resulting filtered optical signal is applied to an optical-to-electrical (O/E) converter to produce an electrical output signal. | 08-27-2009 |
20090238557 | Self-Calibrating Integrated Photonic Circuit and Method of Control Thereof - A self-calibrating integrated photonic circuit and a method of controlling the same. In one embodiment, the circuit includes: (1) a substrate, (2) a laser located on the substrate and configured to produce source light at an output frequency, (3) a laser alignment sensor located on the substrate and including: (3a) a reference optical resonator configured to receive the source light, have a null proximate a predetermined center frequency and provide output light as a function of a relationship between the output frequency and the center frequency and (3b) a photodetector configured to provide an electrical signal of a magnitude that is based on the output light and (4) a calibration controller located on the substrate, coupled to the photodetector and configured to adjust the output frequency based on the magnitude. | 09-24-2009 |
20100119226 | RECONFIGURABLE DWDM WAVELENGTH SWITCH BASED ON COMPLEMENTARY BANDPASS FILTERS - Programmable wavelength line switches and routers based on a complementary wavelength switch (CWS) building block are described for switching optical signals of different wavelengths between signal lines, with each carrying multiple wavelengths. The CWS building block is based on a complementary bandpass filter structure. The reconfigurable wavelength routers described allow any of a plurality of wavelengths on any line to be switched to any output line by programming the filters accordingly. The various implementations described are useful for wavelength division multiplexing (WDM), dense WDM, and ultra dense WDM optical communications systems, as well as for on-chip interconnects and optical signal processing. | 05-13-2010 |
20100247103 | Method and apparatus of microwave photonics signal processing - A radiofrequency (rf) signal-processing device offers the possibility of high bandwidth operation. The disclosed device applies principles of microwave photonics and Linear Amplification based on Nonlinear Components (LINC). For some applications, the device may be embodied in an rf amplifier or rf transmitter. In an embodiment, an optical phase modulator is configured to receive an optical carrier signal as input, and further configured so that, when driven by an rf modulation signal, it will produce a complementary pair of optical signals as output. Each of a pair of detectors is configured to convert a respective one of the complementary optical signals to an rf signal. An rf combiner is configured to add the converted radiofrequency signals from the detectors to form an output signal. | 09-30-2010 |
20110149369 | PHOTONIC MATCH FILTER - An optical path is configured to propagate an input optical signal. A plurality of electrodes are configured to produce a plurality of discrete phase shifts on the optical signal. An output optical signal is phase-shifted with respect to the input optical signal by a sum of the plurality of discrete phase shifts. | 06-23-2011 |
20110149370 | Photonic Technique For Generating Arbitrary Waveforms - In a radio frequency (RF)-photonic arbitrary waveform generator (AWG), an optical carrier signal is phase-modulated using an arbitrary waveform optical phase generator (AWPOG), which may include, e.g., sequential optical phase modulators. The phase-modulated optical signal is combined with a version of the optical carrier signal to yield an optical waveform, whose amplitude varies with a phase shift introduced by the AWPOG to the optical carrier signal. By manipulating electrical inputs to the AWPOG which control the phase shift, the optical waveform can be arbitrary shaped. The optical waveform may then be converted to an electrical waveform having a radio frequency. | 06-23-2011 |
20120121268 | Method And Apparatus Of Microwave Photonics Signal Processing - A radiofrequency (rf) signal-processing device offers the possibility of high bandwidth operation. The disclosed device applies principles of microwave photonics and Linear Amplification based on Nonlinear Components (LINC). For some applications, the device may be embodied in an rf amplifier or rf transmitter. In an embodiment, an optical phase modulator is configured to receive an optical carrier signal as input, and further configured so that, when driven by an rf modulation signal, it will produce a complementary pair of optical signals as output. Each of a pair of detectors is configured to convert a respective one of the complementary optical signals to an rf signal. An rf combiner is configured to add the converted radiofrequency signals from the detectors to form an output signal. | 05-17-2012 |
Patent application number | Description | Published |
20090317488 | Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof - A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations. | 12-24-2009 |
20100166858 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES - A coated drug-ion exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. The drug-ion exchange resin complex is in admixture with a release retardant. The coating is a polyvinyl acetate polymer and a plasticizer. Methods of making and products containing this coated complex are described. | 07-01-2010 |
20120015030 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES - A solid dose composition containing a mixture of a cured, modified release-barrier coated methylphenidate-ion exchange resin complex-matrix and an uncoated methylphenidate-ion exchange resin complex is described. The barrier coated methylphenidate-ion exchange resin complex-matrix comprises methylphenidate complexed with a pharmaceutically acceptable ion-exchange resin to form the complex which is admixed with a polymer to form a methylphenidate-ion exchange resin complex-matrix, which is subsequently coated with a modified release coating. The modified coating contains polyvinyl acetate polymer and a plasticizer and is cured. | 01-19-2012 |
20120207824 | ORALLY EFFECTIVE METHYLPHENIDATE EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION PRODUCT - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 08-16-2012 |
20130004452 | Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof - A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations. | 01-03-2013 |
20130004571 | Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 01-03-2013 |
20130059007 | Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes - A coated drug-ion exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. The drug-ion exchange resin complex is in admixture with a release retardant. The coating is a polyvinyl acetate polymer and a plasticizer. Methods of making and products containing this coated complex are described. | 03-07-2013 |
20130136797 | Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes - An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. The coating is a polyvinyl acetate polymer and a plasticizer. Methods of making the coated complex and the liquid suspension are described. | 05-30-2013 |
20130261152 | ORALLY EFFECTIVE METHYLPHENIDATE EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION PRODUCT - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 10-03-2013 |
20140004160 | ORALLY EFFECTIVE METHYLPHENIDATE EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION PRODUCT | 01-02-2014 |
20140030334 | Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes - An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. The coating is a polyvinyl acetate polymer and a plasticizer. Methods of making the coated complex and the liquid suspension are described. | 01-30-2014 |
20140056984 | Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes - An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described. | 02-27-2014 |
20140093578 | NOVEL CLONIDINE FORMULATION - An oral clonidine dosage unit providing a twenty-four hour extended release profile following a single dose administration is provided. The dosage unit comprises a pharmaceutically effective amount of a coated complex comprising clonidine bound to a cationic exchange resin, which is characterized by a twenty-four hour release profile with a single peak, wherein said oral clonidine dosage unit provides a therapeutically effective plasma concentration for at least about 70%, or at least 85% of the twenty-four hour period following the single dose administration. Both liquid and solid formulations are provided, as are methods of treating a patient by a single administration of a formulation of the invention so as to achieve a therapeutic effect for 24-hours. | 04-03-2014 |
20140127306 | Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes - An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described. | 05-08-2014 |
20140212493 | Highly Bioavailable Composition Containing Eprosartan - Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex - A composition including an association complex of a pharmaceutical composition and one or more polyethylene-polypropylene glycol block copolymers (poloxamers) is provided. The pharmaceutical composition may include a member selected from the group consisting of (a) an association complex of an eprosartan composition including eprosartan or a pharmaceutically acceptable salt of eprosartan and (b) the non-zwitterionic compound 2-(7-chloro-S-methyl-4-oxo-3-phenyl-4,S dihydro-3H-pyridazino (4,S-b)indol-1-yl)N, N-dimethylacetamide (NZ). | 07-31-2014 |
20140271857 | BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES - A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay. The modified release may be provided by (a) a high melt temperature, water-insoluble wax or waxy substance, (b) a low viscosity hydrophilic polymer such a hydroxypropyl methylcellulose, (c) a reverse enteric coating, or combinations thereof. The benzonatate may be in an adsorbate with a silico or silicate or in a complex with a weak acidic ion exchange resin complex. | 09-18-2014 |
20140287038 | Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 09-25-2014 |
20140287041 | Methylphenidate Extended Release Chewable Tablet - An oral methylphenidate extended release tablet is described, which can be scored and still retain its extended release profile. The tablet contains a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and an uncomplexed methylphenidate active component. Following administration of a single dose of the extended release methylphenidate chewable tablet, a therapeutically effective amount of methylphenidate is reached in less than about 20 minutes and the composition provides a twelve-hour extended release profile. | 09-25-2014 |
20140294916 | Methylphenidate Extended Release Chewable Tablet - An oral methylphenidate extended release tablet is described, which can be scored and still retain its extended release profile. The tablet contains a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and an uncomplexed methylphenidate active component. Following administration of a single dose of the extended release methylphenidate chewable tablet, a therapeutically effective amount of methylphenidate is reached in less than about 20 minutes and the composition provides a twelve-hour extended release profile. | 10-02-2014 |
20150024059 | Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes - An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described. | 01-22-2015 |
20150086641 | Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 03-26-2015 |